<bill session="117" type="s" number="3257" updated="2023-09-12T14:00:29Z">
  <state datetime="2021-11-18">REFERRED</state>
  <status>
    <introduced datetime="2021-11-18"/>
  </status>
  <introduced datetime="2021-11-18"/>
  <titles>
    <title type="display">A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to lengthen the period of time during which certain controlled substances must be administered to a patient after being delivered by a pharmacy to the administering practitioner.</title>
  </titles>
  <sponsor bioguide_id="S001181"/>
  <cosponsors>
    <cosponsor bioguide_id="C001047" joined="2021-11-18"/>
  </cosponsors>
  <actions>
    <action datetime="2021-11-18">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-11-18" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSJU" name="Senate Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="5950" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
  </subjects>
  <amendments/>
  <summary date="2023-09-12T13:57:45Z" status="Introduced in Senate">This bill increases the number of days&#8212;from 14 to 60&#8212;within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy. Additionally, the bill revises the process by which the Department of Justice may modify the number of days within which such drugs must be administered.</summary>
</bill>
